Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy TrialVida Terzić, Kévin Bouiller, Drifa Belhadi et al.|Clinical Infectious Diseases|2024Cited by 14
High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I InterferonsAstrid Marchal, Charles Cazanave, Thibault Kerdiles et al.|The Journal of Infectious Diseases|2026Cited by 0